Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections
- PMID: 29132317
- PMCID: PMC5682641
- DOI: 10.1186/s12864-017-4260-y
Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections
Abstract
Background: Amplicon deep sequencing permits sensitive detection of minority clones and improves discriminatory power for genotyping multi-clone Plasmodium falciparum infections. New amplicon sequencing and data analysis protocols are needed for genotyping in epidemiological studies and drug efficacy trials of P. falciparum.
Methods: Targeted sequencing of molecular marker csp and novel marker cpmp was conducted in duplicate on mixtures of parasite culture strains and 37 field samples. A protocol allowing to multiplex up to 384 samples in a single sequencing run was applied. Software "HaplotypR" was developed for data analysis.
Results: Cpmp was highly diverse (He = 0.96) in contrast to csp (He = 0.57). Minority clones were robustly detected if their frequency was >1%. False haplotype calls owing to sequencing errors were observed below that threshold.
Conclusions: To reliably detect haplotypes at very low frequencies, experiments are best performed in duplicate and should aim for coverage of >10'000 reads/amplicon. When compared to length polymorphic marker msp2, highly multiplexed amplicon sequencing displayed greater sensitivity in detecting minority clones.
Keywords: Amplicon sequencing; HaplotypR software; Haplotype clustering; Malaria; Multi-clone infections; Plasmodium falciparum; SNP; cpmp; csp; msp2.
Conflict of interest statement
Ethics approval and consent to participate
Ethical clearance was obtained from PNG Institute of Medical Research Institutional Review Board (IRB 07.20) and PNG Medical Advisory Committee (07.34). Informed written consent was obtained from all parents or guardians prior to recruitment of each child. No medical records were used for this study.
Consent for publication
Not Applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures





Similar articles
-
Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs.Sci Rep. 2019 Nov 28;9(1):17790. doi: 10.1038/s41598-019-54203-0. Sci Rep. 2019. PMID: 31780741 Free PMC article.
-
Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study.Lancet Microbe. 2024 Nov;5(11):100914. doi: 10.1016/S2666-5247(24)00153-8. Epub 2024 Oct 17. Lancet Microbe. 2024. PMID: 39426395
-
Genotyping Plasmodium falciparum gametocytes using amplicon deep sequencing.Malar J. 2024 Apr 6;23(1):96. doi: 10.1186/s12936-024-04920-3. Malar J. 2024. PMID: 38582837 Free PMC article.
-
Molecular approaches to monitor parasite genetic complexity in the transmission of Plasmodium falciparum malaria.Parassitologia. 2005 Jun;47(2):199-203. Parassitologia. 2005. PMID: 16252474 Review.
-
Molecular approaches to determine the multiplicity of Plasmodium infections.Malar J. 2018 Apr 23;17(1):172. doi: 10.1186/s12936-018-2322-5. Malar J. 2018. PMID: 29685152 Free PMC article. Review.
Cited by
-
Population structure and diversity of Plasmodium falciparum in children with asymptomatic malaria living in different ecological zones of Ghana.BMC Infect Dis. 2021 May 13;21(1):439. doi: 10.1186/s12879-021-06120-9. BMC Infect Dis. 2021. PMID: 33985447 Free PMC article.
-
Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.Sci Rep. 2022 Apr 1;12(1):5563. doi: 10.1038/s41598-022-09474-5. Sci Rep. 2022. PMID: 35365711 Free PMC article.
-
Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health.bioRxiv [Preprint]. 2025 Feb 19:2024.08.22.609145. doi: 10.1101/2024.08.22.609145. bioRxiv. 2025. Update in: Sci Rep. 2025 Mar 28;15(1):10737. doi: 10.1038/s41598-025-94716-5. PMID: 39229023 Free PMC article. Updated. Preprint.
-
Identification of Trichinella taxa by ITS-1 amplicon next-generation sequencing with an improved resolution for detecting underrepresented genotypes in mixed natural infections.Parasit Vectors. 2023 Dec 21;16(1):466. doi: 10.1186/s13071-023-06035-1. Parasit Vectors. 2023. PMID: 38129932 Free PMC article.
-
Within-household clustering of genetically related Plasmodium falciparum infections in a moderate transmission area of Uganda.Malar J. 2021 Feb 2;20(1):68. doi: 10.1186/s12936-021-03603-7. Malar J. 2021. PMID: 33531029 Free PMC article.
References
-
- World Health Organization . Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. 2008.
-
- Falk N, Maire N, Sama W, Owusu-Agyei S, Smith T, Beck H-P, et al. Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of plasmodium falciparum. Am J Trop Med Hyg. 2006;74:944–950. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources